四川和谐双马股份有限公司 内部审计制度 第一章 总则 第一条 为规范四川和谐双马股份有限公司（以下简称"公司"）内部审 计工作，加强公司内部审计监督和风险控制，保护投资者合法权益，根据《中 华人民共和国审计法》《审计署关于内部审计工作的规定》《深圳证券交易所上 市公司自律监管指引第 1 号——主板上市公司规范运作》等有关法律、行政 法规、部门规章、规范性文件以及《四川和谐双马股份有限公司章程》（以下 简称"《公司章程》"）的相关规定，结合公司实际情况，特制定本制度。 第二条 本制度所称内部审计，是指公司内部审计部门或内部审计人员对 公司财务收支、经济活动、内部控制、风险管理等实施独立、客观的监督、评 价和建议，以促进公司完善治理、实现目标的活动。 第三条 本制度适用于公司各内部机构或者职能部门、控股子公司以及对 公司具有重大影响的参股公司，前述主体应当配合内部审计机构依法履行职责， 不得妨碍内部审计机构的工作。 第四条 本制度所称内部控制，是指由公司董事会、高级管理人员以及全 体员工共同实施，旨在实现以下控制目标，贯穿企业经营活动的控制过程。 （一）保证公司经营管理合法合规； （五）促进公司实现发展战略。 第 ...

Group 1 - The core point of the news is that Sichuan Shuangma conducted a block trade on October 28, with a total of 115,000 shares traded at a price of 18.1 yuan, which is an 8.08% discount compared to the market closing price of 19.69 yuan [1][2]. Group 2 - The block trade accounted for 1.65% of the total trading volume on that day, with a transaction value of 2.0815 million yuan [1][2]. - The buyer of the block trade was an institutional investor, specifically from CITIC Securities Co., Ltd. Beijing Dongcheng Branch [2].

Group 1 - Sichuan Shuangma's stock price increased by 5.08%, reaching 20.28 CNY per share, with a trading volume of 156 million CNY and a turnover rate of 1.03%, resulting in a total market capitalization of 15.483 billion CNY [1] - Sichuan Shuangma was established on October 20, 1998, and listed on August 24, 1999. The company operates in the building materials industry and private equity fund investment management [1] - The revenue composition of Sichuan Shuangma includes private equity fund management at 33.36%, cement at 32.46%, biomedicine at 23.08%, and aggregates at 11.10% [1] Group 2 - Guotai Fund holds a significant position in Sichuan Shuangma, with the Guotai CSI All-Share Building Materials ETF (159745) owning 673,800 shares, accounting for 2.45% of the fund's net value, ranking as the tenth largest holding [2] - The Guotai CSI All-Share Building Materials ETF (159745) was established on June 9, 2021, with a current size of 502 million CNY. Year-to-date returns are 11.14%, ranking 3541 out of 4218 in its category [2] - The fund has a one-year return of 8.62%, ranking 3416 out of 3876, and has experienced a cumulative loss of 35.26% since inception [2]

Core Viewpoint - The diversified financial sector experienced a slight increase of 0.37% on October 23, with Ruida Futures leading the gains. The Shanghai Composite Index closed at 3922.41, up 0.22%, while the Shenzhen Component Index also rose by 0.22% to 13025.45 [1]. Group 1: Market Performance - The diversified financial sector's stocks showed varied performance, with Ruida Futures closing at 23.13, up 6.34%, and Zhejiang Dongfang at 6.31, up 4.30% [1]. - The trading volume for Ruida Futures was 294,400 hands, with a transaction value of 674 million yuan [1]. - Other notable performers included Hongye Futures, which rose by 3.14% to 11.50, and Nanhua Futures, which increased by 2.79% to 21.73 [1]. Group 2: Capital Flow - The diversified financial sector saw a net outflow of 137 million yuan from major funds, while retail investors contributed a net inflow of 152 million yuan [2]. - Major funds showed a significant net inflow in Ruida Futures, amounting to 99.64 million yuan, representing 14.79% of its total trading [3]. - In contrast, Zhejiang Dongfang experienced a net outflow of 18.60 million yuan from major funds, indicating a negative sentiment among institutional investors [3].

Core Viewpoint - Sichuan Shuangma (000935) is steadily advancing its various business operations, and investors are encouraged to monitor the company's announcements for specific performance details [1] Group 1 - The company is actively responding to investor inquiries on its performance [1] - The company emphasizes the stability of its business progress [1]

Core Viewpoint - Sichuan Shuangma is currently maintaining stable production and operations, focusing on enhancing operational efficiency, optimizing asset quality, and improving profitability to create a solid value foundation for shareholders [2] Group 1 - The company is committed to continuous improvement in operational efficiency [2] - The company aims to optimize asset quality as part of its strategic initiatives [2] - The focus on enhancing profitability is intended to provide stable returns for shareholders [2]

Market Overview - The diversified financial sector experienced a decline of 2.68% on October 17, with Hainan Huate leading the drop [1] - The Shanghai Composite Index closed at 3839.76, down 1.95%, while the Shenzhen Component Index closed at 12688.94, down 3.04% [1] Stock Performance - Notable gainers included *ST Rindong, which rose by 4.38% to a closing price of 6.91, and Bohai Leasing, which increased by 1.78% to 3.44 [1] - Hainan Huate saw the largest decline, dropping 6.96% to a closing price of 7.09, with a trading volume of 3.57 million shares and a transaction value of 2.50 billion [2] - Other significant decliners included Sichuan Shuangma (-5.82%), State Grid Yingda (-4.77%), and Sinopec Capital (-4.72%) [2] Capital Flow - The diversified financial sector saw a net outflow of 666 million from institutional investors, while retail investors contributed a net inflow of 602 million [2] - The table of capital flow indicates that Bohai Leasing had a net inflow of 85.51 million from institutional investors, while it faced a net outflow of 21.25 million from speculative funds [3] - The overall trend shows a mixed capital flow, with institutional investors withdrawing while retail investors remained active in the market [3]

Policy Developments - The National Healthcare Security Administration (NHSA) announced that by the end of 2025, all coordinated areas in the country must implement instant settlement for medical insurance funds [2] - By the end of 2026, instant settlement funds should account for over 80% of the local medical insurance fund's monthly settlement funds, covering various medical expenses [2] Industry Developments - Jiangxi Province is promoting the development of modern seed industry for traditional Chinese medicine, focusing on the protection of medicinal material resources and the establishment of breeding bases [3] - The company Jiuzhoutong received approval for the market launch of the chemical raw material drug, Glycopyrrolate, which will enhance its product line and market competitiveness [5] - Sichuan Shuangma's subsidiary obtained approval for the chemical raw material drug, Leuprolide Acetate, further strengthening its competitive advantage in the domestic raw material drug sector [6] Financial Reports - Guobang Pharmaceutical reported a 23.17% year-on-year increase in net profit for Q3, despite a 5.39% decline in revenue [8] Investment Activities - OxTium Technology completed several million yuan in angel+ round financing, led by Sequoia China Seed Fund [11] Clinical Research - Eli Lilly announced positive results from two Phase 3 clinical trials for orforglipron, showing significant improvements in blood sugar control and weight loss for type 2 diabetes patients [14] Shareholder Actions - Kangtai Medical announced that major shareholder Wang Guili reduced her holdings by 4.24 million shares, decreasing her ownership to 8.95% [17]

Core Viewpoint - Sichuan Shuangma announced that its subsidiary, Hubei Jianxiang Biopharmaceutical Co., Ltd., has received the approval notice for the listing application of Acetyl-L-carnitine from the National Medical Products Administration [1] Group 1 - The approval is significant for the company as it expands its product offerings in the pharmaceutical sector [1] - The approval indicates a positive regulatory environment for the company's operations and potential growth in the biopharmaceutical market [1]

Group 1 - Dingjide's subsidiary has successfully launched the industrial production of POE materials, achieving stable production of qualified products [1] - Xinhua Insurance reported a 19% year-on-year increase in original insurance premium income for the first three quarters, totaling 172.705 billion yuan [1] - Chunfeng Power achieved a 30.89% year-on-year increase in net profit for the first three quarters, with total revenue reaching 14.15 billion yuan [1][2] Group 2 - Guangsheng Nonferrous expects a net profit of 100 million to 130 million yuan for the first three quarters, marking a turnaround from losses [1] - Aobi Zhongguang anticipates a net profit of approximately 108 million yuan for the first three quarters, with revenue growth of 103.5% [1] - Guobang Pharmaceutical reported a 15.78% year-on-year increase in net profit for the first three quarters, totaling 6.7 billion yuan [1] Group 3 - Zhujiang Co. manages 428 projects with a signed construction area of approximately 50.9853 million square meters as of September 2025 [1] - Kecuan Technology has terminated its application for issuing convertible bonds, considering its development plan and actual situation [1] - Guoxin Securities has received approval to register 15 billion yuan in short-term corporate bonds [1] Group 4 - Aihua Pharmaceutical's clinical trial for a pediatric cough syrup has been approved by the National Medical Products Administration [1] - Xinjiang Jiaojian signed new construction contracts worth 1.413 billion yuan in the third quarter [1] - Sichuan Shuangma's subsidiary has received approval for the listing of a raw material drug used in treating various diseases [1] Group 5 - Gansu Energy's 1,000 MW coal-fired unit has officially commenced commercial operation [1] - Zhejiang Energy reported a 4.68% year-on-year increase in power generation for the first three quarters, totaling 135.234 billion kWh [1] - Tiandi Source's contract sales amount for the first nine months decreased by 16.18% to 3.085 billion yuan [1] Group 6 - Biological Shares' subsidiary has obtained a new veterinary drug registration certificate for a vaccine [1] - Jintong Co. reported a 4.03% year-on-year increase in net profit for the first three quarters, totaling 2.283 billion yuan [1] - Rihua Technology plans to invest 800 million yuan in a new project for industrial ray detection equipment [1] Group 7 - Zhongtian Technology has won multiple marine project bids totaling approximately 1.788 billion yuan [1] - Qingsong Co. has completed the disposal of a 148-acre industrial park project, transferring it for 163 million yuan [1] - Tongyuan Petroleum has successfully bid for a $126 million oil and gas service project in Algeria [1] Group 8 - Hengmingda's chairman proposed a share buyback plan of 200 million to 400 million yuan [1] - Deyi Cultural plans to reduce its holdings by up to 1% of the company's shares [1] - Feirongda's major shareholder plans to reduce its holdings by up to 2.36% of the company's shares [1] Group 9 - Mankun Technology plans to issue convertible bonds to raise no more than 760 million yuan for high-end PCB production and digital upgrades [1] - Sanlian Forging's shareholder plans to reduce its holdings by up to 3% of the company's shares [1] - Huagong Technology intends to jointly establish a venture capital fund with a target size of 500 million yuan [1] Group 10 - Shida Shenghua expects a net loss of 49 million to 75 million yuan for the first three quarters [1] - Huichuangda's major shareholder plans to reduce its holdings by up to 0.65% of the company's shares [1] - Yuxin Electronics reported a 60.21% year-on-year increase in net profit for the first three quarters, totaling 73.3941 million yuan [1] Group 11 - Yiwei Communication expects a 50% to 55% decline in net profit for the first three quarters [1] - Lio Co. plans to reduce its repurchased shares by up to 135 million shares [1] - Sichuan Shuangma's subsidiary has received approval for a new drug registration [1]